Johnson & Johnson: Changing health for humanity Skip to content

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.

Blood cells under a microscope

Innovative Medicine

Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.

MedTech

Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.

Solving the toughest health challenges

Health & wellness
FINAL LEDE- 5 Things We Now Know About Colorectal Cancer- Colorectal cancer colitis graphic

5 things we now know about colorectal cancer

Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.

Heart failure is probably not what you think it is

For American Heart Month, learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
Innovation
Close-up of a woman with low vision receiving an eye exam exam with a doctor shining light into her left eye

What is low vision?

Low vision isn’t the same as blindness, but navigating daily life with it is still challenging. For Low Vision Awareness Month, learn the facts—plus, the promising treatment innovations that are in the works.
Innovation
A female scientist conducting research in a laboratory, focusing on orphan drugs for rare diseases

How orphan drugs are giving patients more options

The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.
Innovation
Pregnant woman looking at sonogram

What to know about HDFN, a serious blood disorder in babies, including a possible new treatment

Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That’s why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.

2024 Annual Meeting of Shareholders

April 25, 2024, 10 AM Eastern Time
Latest news
healthcare worker in protective medical gear

Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
Personal stories
Jennefer Wetzel, Ganendra Awang Kristandya, Zolelwa Sifumba, M.D., and Saurabh Rane are working to end TB

“We want a world without tuberculosis in our lifetimes”

Healthcare providers who contracted TB on the job. A microbiologist researching new treatments. An activist ensuring attention is paid to one of the world’s greatest health threats. These young leaders share one goal: to help end TB.
Innovation
5-Things-We-Now-Know-About-Multiple-Myeloma-1122.png

5 things we now know about multiple myeloma

Rates of this blood cancer have jumped more than 125% worldwide since the 1990s. But there’s reason to have hope: Today, life expectancy has at least doubled in some cases. That’s thanks to increased research, new learnings and innovative advances—and Johnson & Johnson is at the forefront of this crucial work.
Innovation
Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

How cardiac ablation may help treat heart conditions

For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
Innovation
Scientist examining a sample in a petri dish

Could we be on our way to eliminating cancer for good?

What once seemed like an out-of-reach goal may soon be within our grasp. Take an in-depth look at how Johnson & Johnson is working toward its vision of helping create a world without cancer.
Innovation
0324 3 Scientists 3x4.png

Meet 3 leaders who are breaking new ground for women in healthcare

For International Women’s Day, celebrate the achievements of these amazing female scientists and researchers at Johnson & Johnson.
Health & wellness
A woman looking at her eye in a compact mirror

What we now know about myasthenia gravis

For National Autoimmune Disease Awareness Month, discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.
Innovation
Black female scientist with blue gloves looking through a microscope

How Johnson & Johnson is advancing new options for bladder cancer treatment

Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
Caring & giving
Sam Seavey piloting an aircraft from the cockpit

3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
Innovation
A doctor in purple gloves and a blue gown holding a catheter for AFib

5 things we now know about atrial fibrillation

More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. For American Heart Month, learn the facts behind this heart condition, plus one patient’s diagnosis story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.